- Rating
- 4
- Confidence
- 2
- Informativeness
- 2
- Presentation
- 3
- Soundness
- 3
Read review
Paper summary
At its core, SimpleFold2 treats biomolecular co-folding like a standard generative task. Instead of relying on the heavy, highly specialized machinery of AlphaFold (like those notoriously slow triangular updates or deep MSA stacks), it strips everything back to a general-purpose transformer.
By fusing pre-trained language models in an encoder-decoder setup, it gets the evolutionary context it needs without the computational bloat. They scaled this brute-force, simple architecture up to 3.3 billion parameters, and the payoff is massive: it folds huge 5,000-residue complexes on a single GPU up to 10x faster than AF3-style models, using just a fraction of the memory.
Overall, I think this is a work with substantial innovation.
Critical strengths
- Speed and Memory: It’s incredibly fast and lean. Running ~10x faster with roughly 70% less memory makes it genuinely viable for massive high-throughput screening and agent-driven workflows.
- No More Size Limits: Getting rid of cubic scaling means the traditional memory bottleneck is gone. Folding nearly 5,000 residues on a single H100 in under a minute is a huge practical win.
- Unseen Ligand Prediction: It punches way above its weight on novel protein-ligand pockets, matching or beating heavily specialized open-source models on data it hasn't seen before.
- Test-Time Scaling: Because a single run is so computationally cheap, you can just throw compute at it, sample a ton of structural candidates, and easily hit a new Pareto frontier for time-vs-accuracy.
Critical weaknesses
- Brute-Force Parameter Cost: It takes 3.3 billion parameters to do what AlphaFold-style models accomplish with a few hundred million. It's fast at inference, but it's fundamentally less parameter-efficient.
- Data Hungry: If the public PDB doesn't have a massive amount of training data for a specific interaction (like antibody-antigen or protein-RNA), this model struggles more than the state-of-the-art baselines.
- Lower Single-Shot Accuracy: Its "first guess" isn't always as accurate as highly specialized models, particularly for protein-protein interactions. It relies heavily on its blazing speed to generate multiple samples and pick the best one.
- Missing Historical Context (Literature): While the paper extensively cites the latest 2024/2025 AF3 derivatives, it misses the foundational works that actually paved the way for this "pLM-only, simplified" philosophy. The authors should cite OmegaFold and the original ESMFold to acknowledge the pioneers of MSA-free folding. Additionally, referencing early generative deep learning models for protein-ligand docking (like DiffDock) would provide a more complete historical context for their impressive ligand results.
- Open-Source Availability: The claims about efficiency and speed are phenomenal, but currently, the paper is under double-blind review and lacks a code repository. The community can only verify and build upon this if the code and model weights are released. I strongly encourage the authors to fully open-source their codebase and the 3.3B model weights upon publication.
Questions for authors
Nothing
Official Comment from Authors to Reviewer ZU2z
Thank you for your positive review and your helpful suggestions.
Q1. Parameter count.
Q2. Data requirements and single-shot accuracy.
Q3. Additional related work.
Q4. Code and weights release.